Literature DB >> 19889986

Brain gray matter decrease in chronic pain is the consequence and not the cause of pain.

Rea Rodriguez-Raecke1, Andreas Niemeier, Kristin Ihle, Wolfgang Ruether, Arne May.   

Abstract

Recently, local morphologic alterations of the brain in areas ascribable to the transmission of pain were reported in patients suffering from chronic pain. Although some authors discussed these findings as damage or loss of brain gray matter, one of the key questions is whether these structural alterations in the cerebral pain-transmitting network precede or succeed the chronicity of pain. We investigated 32 patients with chronic pain due to primary hip osteoarthritis and found a characteristic gray matter decrease in patients compared with controls in the anterior cingulate cortex (ACC), right insular cortex and operculum, dorsolateral prefrontal cortex (DLPFC), amygdala, and brainstem. We then investigated a subgroup of these patients (n = 10) 6 weeks and 4 months after total hip replacement surgery, monitoring whole brain structure. After surgery, all 10 patients were completely pain free and we observed a gray matter increase in the DLPFC, ACC, amygdala, and brainstem. As gray matter decrease is at least partly reversible when pain is successfully treated, we suggest that the gray matter abnormalities found in chronic pain do not reflect brain damage but rather are a reversible consequence of chronic nociceptive transmission, which normalizes when the pain is adequately treated.

Entities:  

Mesh:

Year:  2009        PMID: 19889986      PMCID: PMC6666725          DOI: 10.1523/JNEUROSCI.3687-09.2009

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  168 in total

1.  The brain in chronic pain: clinical implications.

Authors:  A Vania Apkarian
Journal:  Pain Manag       Date:  2011-11-01

Review 2.  Variations in brain gray matter associated with chronic pain.

Authors:  Patrick B Wood
Journal:  Curr Rheumatol Rep       Date:  2010-12       Impact factor: 4.592

3.  Chronic pain epidemiology - where do lifestyle factors fit in?

Authors:  Oliver van Hecke; Nicola Torrance; Blair H Smith
Journal:  Br J Pain       Date:  2013-11

4.  Cognitive Functioning after Surgery in Middle-aged and Elderly Danish Twins.

Authors:  Unni Dokkedal; Tom G Hansen; Lars S Rasmussen; Jonas Mengel-From; Kaare Christensen
Journal:  Anesthesiology       Date:  2016-02       Impact factor: 7.892

5.  Alterations in endogenous opioid functional measures in chronic back pain.

Authors:  Ilkka K Martikainen; Marta Peciña; Tiffany M Love; Emily B Nuechterlein; Chelsea M Cummiford; Carmen R Green; Richard E Harris; Christian S Stohler; Jon-Kar Zubieta
Journal:  J Neurosci       Date:  2013-09-11       Impact factor: 6.167

Review 6.  Neurological diseases and pain.

Authors:  David Borsook
Journal:  Brain       Date:  2011-11-08       Impact factor: 13.501

7.  Neuropathic Pain Creates an Enduring Prefrontal Cortex Dysfunction Corrected by the Type II Diabetic Drug Metformin But Not by Gabapentin.

Authors:  Stephanie Shiers; Grishma Pradhan; Juliet Mwirigi; Galo Mejia; Ayesha Ahmad; Sven Kroener; Theodore Price
Journal:  J Neurosci       Date:  2018-07-20       Impact factor: 6.167

8.  Altered Associations between Pain Symptoms and Brain Morphometry in the Pain Matrix of HIV-Seropositive Individuals.

Authors:  Deborrah Castillo; Thomas Ernst; Eric Cunningham; Linda Chang
Journal:  J Neuroimmune Pharmacol       Date:  2017-09-02       Impact factor: 4.147

9.  Altered resting state functional connectivity of the cognitive control network in fibromyalgia and the modulation effect of mind-body intervention.

Authors:  Jian Kong; Emily Wolcott; Zengjian Wang; Kristen Jorgenson; William F Harvey; Jing Tao; Ramel Rones; Chenchen Wang
Journal:  Brain Imaging Behav       Date:  2019-04       Impact factor: 3.978

10.  Brain white matter structural properties predict transition to chronic pain.

Authors:  Ali R Mansour; Marwan N Baliki; Lejian Huang; Souraya Torbey; Kristi M Herrmann; Thomas J Schnitzer; A Vania Apkarian
Journal:  Pain       Date:  2013-10       Impact factor: 6.961

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.